Press Releases

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a grant to the TB Alliance as a member

The TB Alliance and its partners have completed patient enrollment in REMox TB, a global Phase III clinical trial, which

(Durban, SOUTH AFRICA,) The TB Alliance today announced the launch of a collaboration with the National Institute of Allergy and

· AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization sign partnership to share information on TB drugs

(NEW YORK, USA) Tuberculosis (TB) is widely considered a public health concern and its treatment a public sector responsibility. But

[BEIJING, China, Beijing]The International Scientific Exchange Foundation of China (ISEFC), a technical public foundation dedicated to promoting and advancing scientific

The Global Alliance for TB Drug Development (TB Alliance) today announced the appointment of James T. Morris to its Board

The TB Alliance announced today the appointment of three new Scientific Advisors. These professionals bring with them diverse areas of

December 20, 2010, New York: The Global Alliance for TB Drug Development (TB Alliance) has received a five-year grant from

The past decade has seen significant progress in scaling up effective treatment and case management programs for tuberculosis (TB) control,